US OptionsDetailed Quotes
KOD250117C4500
- 0.65
- 0.000.00%
15min DelayClose Jan 7 16:00 ET
0.00High0.00Low
0.65Open0.65Pre Close0 Volume38 Open Interest4.50Strike Price0.00Turnover474.95%IV-46.19%PremiumJan 17, 2025Expiry Date5.07Intrinsic Value100Multiplier10DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9134Delta0.0213Gamma1.74Leverage Ratio-0.0608Theta0.0009Rho1.59Eff Leverage0.0025Vega
Kodiak Sciences Stock Discussion
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...
NEWS
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy
NEWS
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform
$EyePoint Pharmaceuticals (EYPT.US)$
$Adverum Biotechnologies (ADVM.US)$
$Regenxbio (RGNX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Kodiak Sciences (KOD.US)$
- 🇺🇸 U.S. stocks had their best week of 2023.
- 💹 Dow Jones gained 0.1%, the S&P 500 rose 0.2%, and the Nasdaq Composite was up 0.3%.
- 📅 Monday marked the Nasdaq's seventh consecutive day of gains, matching a win streak last seen in January.
- 📊 Last week saw significant gains, with the Dow Jones up 5.1%, the S&P 500 up 5.9%, and the Nasdaq Composite up 6.6%.
- 📉 Bond yields tempo...
No comment yet